Abstract
BackgroundThe number of clinical studies evaluating the benefit of cytokine-induced killer cell (CIK) therapy, an adoptive immunotherapy, for colorectal cancer (CRC) is increasing. In many of these trials, CIK therapy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have